The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...
Home »
NDTV News - India-news
» Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug
No comments:
Post a Comment